XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (131,446) $ (58,194)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Loss (gain) on sale or write down of assets, net 36,085 (3,779)
Depreciation and amortization 71,382 75,035
Amortization of share and unit-based plans 2,730 4,895
Straight-line rent and amortization of above and below market leases 3,577 823
Provision for (recovery of) doubtful accounts 2,923 (1,023)
Income tax benefit (1,224) (1,882)
Equity in loss of unconsolidated joint ventures 73,276 61,810
Distributions of income from unconsolidated joint ventures 0 280
Change in fair value of financing arrangement obligation 2,939 (11,885)
Changes in assets and liabilities, net of dispositions:    
Tenant and other receivables 30,598 22,051
Other assets 474 8,645
Due from affiliates (581) (4,592)
Accounts payable and accrued expenses 1,723 1,938
Other accrued liabilities (31,361) (13,392)
Net cash provided by operating activities 61,095 80,730
Cash flows from investing activities:    
Development, redevelopment, expansion and renovation of properties (26,420) (19,992)
Property improvements (7,329) (14,872)
Deferred leasing costs (1,495) (1,217)
Distributions from unconsolidated joint ventures 20,942 162,166
Contributions to unconsolidated joint ventures (12,686) (12,938)
Proceeds from sale of assets 11 5,018
Net cash (used in) provided by investing activities (26,977) 118,165
Cash flows from financing activities:    
Proceeds from mortgages, bank and other notes payable 270,000 420,000
Payments on mortgages, bank and other notes payable (225,244) (538,664)
Deferred financing costs (4,273) (13,251)
Payments on finance leases (615) (593)
Costs from stock offerings 0 (21)
Dividends and distributions (39,201) (41,812)
Net cash provided by (used in) financing activities 667 (174,341)
Net increase in cash, cash equivalents and restricted cash 34,785 24,554
Cash, cash equivalents and restricted cash, beginning of period 190,294 181,139
Cash, cash equivalents and restricted cash, end of period 225,079 205,693
Supplemental cash flow information:    
Cash payments for interest, net of amounts capitalized 48,707 48,376
Non-cash investing and financing transactions:    
Accrued development costs included in accounts payable and accrued expenses and other accrued liabilities $ 43,244 $ 34,526